Free Trial

Madrigal Pharmaceuticals (MDGL) Insider Trading & Ownership

Madrigal Pharmaceuticals logo
$317.09 +2.92 (+0.93%)
(As of 11/20/2024 ET)

Madrigal Pharmaceuticals (NASDAQ:MDGL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.80%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$29.93 M
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$42.30 M
Get MDGL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Madrigal Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MDGL Insider Buying and Selling by Quarter

Madrigal Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2024Richard S LevyDirectorSell5,000$300.94$1,504,700.00  
9/9/2024William John SiboldCEOSell6,363$243.83$1,551,490.29  
6/14/2024Robert E WaltermireVPSell1,900$280.00$532,000.00  
6/12/2024Robert E WaltermireVPSell2,000$285.00$570,000.00  
5/21/2024Robert E WaltermireVPSell1,036$231.34$239,668.24  
5/14/2024Fred B CravesDirectorSell22,489$212.88$4,787,458.32  
4/8/2024Paul A FriedmanDirectorSell26,270$246.19$6,467,411.30  
4/8/2024Rebecca TaubCMOSell2,676$245.99$658,269.24  
4/5/2024Rebecca TaubCMOSell27,506$243.36$6,693,860.16  
4/4/2024Paul A FriedmanDirectorSell18,710$242.96$4,545,781.60  
4/3/2024Rebecca TaubCMOSell27,845$245.14$6,825,923.30  
4/1/2024James M DalyDirectorSell32,489$102.77$3,338,894.53  
4/1/2024Richard S LevyDirectorSell11,000$257.48$2,832,280.00  
12/13/2023Bros. Advisors Lp BakerDirectorBuy81,159$219.39$17,805,473.01  
12/13/2023Robert E WaltermireVPSell2,500$225.40$563,500.00  
12/4/2023Brian Joseph LynchSVPSell1,800$218.87$393,966.00  
11/29/2023Brian Joseph LynchSVPSell4,000$199.19$796,760.00  
11/21/2023Bros. Advisors Lp BakerDirectorBuy64,350$188.47$12,128,044.50  
(Data available from 1/1/2013 forward)

MDGL Insider Trading Activity - Frequently Asked Questions

22.80% of Madrigal Pharmaceuticals stock is owned by insiders. Learn more on MDGL's insider holdings.

The following insider purchased MDGL shares in the last 24 months: Bros. Advisors Lp Baker ($43,382,043.47).

Insiders have purchased a total of 226,067 MDGL shares in the last 24 months for a total of $43,382,043.47 bought.

The following insiders have sold MDGL shares in the last 24 months: Brian Joseph Lynch ($6,787,946.00), Fred B Craves ($4,787,458.32), James M Daly ($3,338,894.53), Paul A Friedman ($11,013,192.90), Rebecca Taub ($14,178,052.70), Remy Sukhija ($8,224,200.00), Richard S Levy ($10,929,630.35), Robert E Waltermire ($1,905,168.24), and William John Sibold ($1,551,490.29).

Insiders have sold a total of 266,073 Madrigal Pharmaceuticals shares in the last 24 months for a total of $62,716,033.33 sold.

Madrigal Pharmaceuticals Key Executives

  • Dr. Rebecca A. Taub M.D. (Age 72)
    Founder, Chief Medical Officer, President of Research & Development and Director
    Compensation: $939.83k
  • Mr. Brian J. Lynch J.D. (Age 62)
    Senior VP & General Counsel
    Compensation: $763.75k
  • Mr. Alex G. Howarth (Age 55)
    Executive Officer
    Compensation: $757.26k
  • Mr. William J. SiboldMr. William J. Sibold (Age 58)
    CEO, President & Director
    1 recent trades
  • Ms. Mardi C. Dier (Age 60)
    CFO, Principal Financial Officer, Principal Accounting Officer & Senior VP
  • Mr. Ronald Filippo
    Chief Information Officer
  • Ms. Tina E. Ventura
    Chief Investor Relations Officer
  • Dr. Kianoush Motesharei Ph.d. (Age 54)
    Senior Vice President of Business & Corporate Development
  • Mr. Clint Wallace
    Chief Human Resources Officer
  • Mr. Edward Chiang
    Senior Vice President of Clinical & Technical Operations


This page (NASDAQ:MDGL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners